Status:
COMPLETED
Dexmedetomidine in Splanchnic Nerve Neurolysis
Lead Sponsor:
Minia University
Conditions:
Dexmedetomidine
Eligibility:
All Genders
25-70 years
Phase:
NA
Brief Summary
Malignancy related abdominal and pelvic pain can be debilitating and affects survival as well as quality of life. Pain from cancer and its treatments can result in anxiety, depression, fear, anger, he...
Detailed Description
Patients fasted for 6 hours prior to the procedure, and a 20 G intravenous cannula was placed. Before the procedure, 500 mL of physiological saline was administered intravenously. The patient was posi...
Eligibility Criteria
Inclusion
- Patient diagnosed to have abdominal malignancy aged 25 to 70 years old
- Fully conscious
- Patient has no hematological disease or coagulation abnormality.
- Patient has no history of mental illness
- Patient with persistent and moderate to severe abdominal pain visual analogue scale score \> 4.
Exclusion
- Patient refusal of the procedure
- Extremes of age
- Patients with psychiatric disorders
- Patient diagnosed to have any coagulation defect or bleeding tendency
- Patients with cardiopulmonary significant condition
- Skin infection or wounds at site of proposed needle insertion site
Key Trial Info
Start Date :
September 30 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 30 2022
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT05291364
Start Date
September 30 2020
End Date
July 30 2022
Last Update
August 1 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Minya University
Minya, Egypt, 61519